ELIZABETH RYAN: Open Payments
NPI 1730655085 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 49 payments from 4 companies in 2025. Trend: 2023 $436 · 2024 $695 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $423 |
| Eisai Inc. | 4 | $95 |
| Lilly USA, LLC | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
Products named: UBRELVY, QULIPTA, Leqembi, AMYVID, AUSTEDO XR, KISUNLA.
Industry payments across MA — which companies pay providers there.
